708 results on '"Malavasi, F."'
Search Results
52. Characterization of a Murine Monoclonal Antibody Specific for Early Lymphohemopoietic Cells
53. Definition by Murine Monoclonal Antibodies of Cell Surface Structures Exerting Fc- and C3Bi-Receptor Activity in Vivo
54. THE LOW-AFFINITY Fc RECEPTOR FOR IgG RECOGNIZED BY MOAB AB8.28 IS CAPABLE OF TRANSDUCING ACTIVATION AND DEGRANULATORY SIGNALS IN LARGE GRANULAR LYMPHOCYTES
55. A Monoclonal Antibody Detects a New Antigenic Determinant Shared by DR1 and DR4/Dw4 Molecules
56. Production and Characterization of Murine Monoclonal Antibodies against Human B Cell Surface Determinants
57. CD38, a novel marker of mature monocyte derived dendritic cells, modulates th-1 adaptative immune response
58. Monoclonal antibodies as selective diagnostic and therapeutical tools in benign and neoplastic prostatic pathologies
59. Characterization of the Murine Monoclonal Antibody NL07 Specific for the Human Thrombospondin Receptor (CD36 Molecule)1
60. Characterization of Hemopoietic Regulatory Factors Released by Unstimulated LGL
61. HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism
62. Gene products of the human CD38 family in physiological and pathological conditions
63. CD38 ligation plays a direct role in the induction of IL-1beta, IL-6, and IL-10 secretion in resting human monocytes
64. CD38 expression and functional activities are up-regulated by IFN-gamma on human monocytes and monocytic cell lines
65. CD38 signals upregulate expression and functions of matrix metalloproteinase-9 in chronic lymphocytic leukemia cells
66. Retinoids in breast cancer prevention and treatment. A review of the literature
67. CD38 in chronic lymphocytic leukemia: from bench to bedside?
68. CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death
69. Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network
70. A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome
71. 519 - Delivery of microRNA-26a by CD38-conjugated nanoparticles into chronic lymphocytic leukemia cells of the Eµ-TCL1 mouse model
72. Analysis of ADP ribosyl cyclase (CD38) in lamina propria T lymphocytes
73. rC5a directs the in vitro migration of human memory and naive tonsillar B lymphocytes: implications for B cell trafficking in secondary lymphoid tissues
74. Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15
75. Transferrin receptor 2 is frequently and highly expressed in glioblastomas
76. CD38 Workshop: The genetic analysis of human CD38
77. Analysis of the distribution of human CD38 and its ligand CD31 in normal tissues
78. Characterization of a CD38-like 78-kilodalton soluble protein from B cell lines derived from patients with X-linked agammaglobulinemia
79. The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia
80. Modulation of lymphocyte interaction with endothelium and homing by HIV-1 gp120
81. Mapping of the catalytic and epitopic sites of human CD38/NAD+ glycohydrolase to a functional domain in the carboxyl terminus
82. CD38 ligation results in activation of the Raf-1/mitogen-activated protein kinase and the CD3-zeta/zeta-associated protein-70 signaling pathways in Jurkat T lymphocytes
83. CD38 and CD157 as receptors of the immune system: a bridge between innate and adaptive immunity
84. Investigation of the potential role of membrane CD38 in protection against cell death induced by HIV-1
85. Human CD38 ligand. A120kDa protein predominantly expressed on endotelial cells
86. CD38 EXPRESSION DISTINGUISHES TWO GROUPS OF B CELL-CHRONIC LYMPHOCYTIC LEUKEMIAS WITH DIFFERENT RESPONSE TO ANTI IgM ANTIBODIES AND PROPENSITY TO APOPTOSIS
87. CD38 signals upregulate expression and functions of matrix metalloproteinase-9 in chronic lymphocytic leukemia cells
88. Radioimmunotherapy in advanced ovarian cancer: Is there a role for pre-targeting with 90Y-biotin?
89. 2.34 CD38 is a Principal Component of the CLL ‘Invadosome’
90. CD38 in Chronic Lymphocytic Leukemia: From Bench to Bedside?
91. Oxytocin receptor nuclear translocation mediates upregulation of osteoblast specific genes
92. P.1.005 Retinoic acid upregulates reduced cd38 transcription in lymphoblastoid cell lines from patients with autism spectrum disorder
93. Interaction between endothelium and CD4+CD45RA+ lymphocytes. Role of the human CD38 molecule
94. Report on the fifth International Workshop on Human Leukocyte Differentiation Antigens
95. 209 Nicotinamide acts as pharmacological agent by promoting apoptosis in chronic lymphocytic leukemia through the activation of the p53/miR-34a/SIRT1 tumour suppressor network
96. Molecular analysis of CD36 molecule in platelet activation
97. Cell surface receptors and bispecific monoclonal antibodies: the link between basic science and medical oncology
98. Reduced expression of macrophage-associated antigens on alveolar mononuclear phagocytes from AIDS patients
99. Chronic lymphocytic leukemia microenvironment: shifting the balance from apoptosis to proliferation
100. Regulation of transferrin receptor 2 in human cancer cell lines
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.